Uterine Delivery Innovators 3 Daughters Health joins WoHX
Boston, MA -- October 8: Women's HealthX is pleased to welcome 3 Daughters Health as a Start-Up Partner for this year's event in Boston.
For decades, innovation in contraception and gynecological care has remained largely stagnant, leaving millions of women to choose between highly systemic hormonal treatments or invasive, painful procedural devices. 3 Daughters Health is looking to disrupt this space entirely with a revolutionary targeted uterine drug delivery platform.
Starting with a groundbreaking frameless, magnetic, non-hormonal contraceptive solution, 3 Daughters is designing technologies that align with a woman's anatomy, drastically reducing insertion pain and minimizing the systemic side effects associated with traditional options.
"The company's clinical vision directly targets the innovation gaps being discussed at Women's HealthX. Throughout the event, investors and biopharma leaders will explore how moving beyond outdated legacy devices to patient-centered, targeted therapeutics is essential for the next wave of commercial growth."
True progress in women's health requires rethinking the fundamental delivery mechanisms of care.
By prioritizing patient comfort and targeted efficacy, 3 Daughters Health is redefining what modern gynecological innovation looks like. We are delighted to welcome 3 Daughters Health to the Women's HealthX community and look forward to showcasing their work this December.
Women’s HealthX 2026 | From Rhetoric to Results
Encore Boston Harbor | December 3-4 2026
Bypass abstract market rhetoric to evaluate real-world health economics, regulatory compliance mandates, and care delivery systems. Join the region's foremost health plan medical directors, hospital COOs, biopharma innovators, and enterprise benefits buyers anchoring our 2026 tracks.
